✦ LIBER ✦

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

✍ Scribed by Christopher J. Logothetis; Arlene Siefker-Radtke

Book ID: 113611771
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 98 KB
Volume: 57
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2010.01.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 clinical trial of sequential n

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer : Final results

✍ Arlene O. Siefker-Radtke; Colin P. Dinney; Yu Shen; Dallas L. Williams; Ashish M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Methotrexate, vinblastine, doxorubicin a

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

✍ Han, K S; Joung, J Y; Kim, T S; Jeong, I G; Seo, H K; Chung, J; Lee, K H 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Platinum-free combination chemotherapy i

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma : A Phase I/II trial of gemcitabine, paclitaxel, and methotrexate

✍ Primo N. Lara Jr; Frederick J. Meyers; Lisa Y. Law; Nancy A. Dawson; Joan Housto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Platinum‐based regimens have improved response rates and survival in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract. However, the toxicities of platinum‐based chemotherapy are considerable. Regimens with reduced toxicity that are applicab

A phase 2 study of sequential neoadjuvan

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

✍ Julka, Pramod K.; Chacko, Raju T.; Nag, Shona; Parshad, Rajinder; Nair, Aravinda 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 244 KB

Methotrexate-paclitaxel-epirubicin-carbo

Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study

✍ Amal Halim; Niveen Abotouk 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Gemcitabine or Gemcitabine Plus Oxalipla

Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group (GETUG V01)

✍ Stéphane Culine; Aude Fléchon; Aline Guillot; Sylvestre Le Moulec; Damien Pouess 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 650 KB